| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.36 | 0.04 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.37 | 0.04 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |